Atlas Trials

Morphine to Maximize the Benefits of Exercise Training in COPD or ILD and Persistent Breathlessness

Clinical trial NCT03824834 · UNKNOWN

Trial details

NCT number
NCT03824834
Sponsor
Dennis Jensen, Ph.D.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary DiseaseInterstitial Lung Disease
Start date
2019-08-06
Primary completion
2020-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.